Valuation Radnostix, Inc.

Stocks

Market Closed - OTC Markets 15:24:10 2026-10-23 EDT			5-day change	1st Jan Change
0.0493 ^USD	+16.44%		+9.56%	-19.51%

10-19	Radnostix, Inc. and Nano Nuclear Energy Announce Joint Submission of Letter of Intent to Nrc Seeking Consent for Transfer of License Sub-1011, Following Lea County Approval of Property Loi	CI
08-12	Radnostix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	21.64	47.23	16.73	20.79	18.01	32.35
Change	-	118.25%	-64.57%	24.25%	-13.38%	79.64%
Enterprise Value (EV) ¹	29.67	55.94	22.47	26.45	24.43	39.56
Change	-	88.54%	-59.83%	17.7%	-7.64%	61.95%
P/E	9.8x	-49.8x	54.8x	-23.8x	2,150x	-35.5x
PBR	37.7x	17.3x	3.85x	5.15x	4.14x	8.76x
PEG	-	0x	-0x	0x	-21x	0x
Capitalization / Revenue	2.31x	4.89x	1.5x	1.69x	1.3x	2.48x
EV / Revenue	3.17x	5.79x	2.01x	2.16x	1.76x	3.03x
EV / EBITDA	-401x	146x	-28.9x	-70.9x	51.1x	-82.4x
EV / EBIT	-71.4x	-232x	-18.7x	-34.1x	3,540x	-41.4x
EV / FCF	41.5x	-96.9x	-14.3x	47.1x	-74.7x	345x
FCF Yield	2.41%	-1.03%	-7%	2.12%	-1.34%	0.29%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.005206	-0.001888	0.000593	-0.001678	0.000016	-0.001723
Distribution rate	-	-	-	-	-	-
Net sales ¹	9.365	9.662	11.18	12.27	13.9	13.07
EBITDA ¹	-0.074	0.3837	-0.7784	-0.3731	0.4783	-0.4801
EBIT ¹	-0.4157	-0.2408	-1.203	-0.7763	0.006901	-0.9562
Net income ¹	2.203	-0.9023	0.3032	-0.869	0.008574	-0.908
Net Debt ¹	8.028	8.708	5.737	5.656	6.416	7.206
Reference price ²	0.0510	0.0940	0.0325	0.0400	0.0344	0.0612
Nbr of stocks (in thousands)	424,344	502,468	514,890	519,788	523,553	528,210
Announcement Date	3/30/21	3/31/22	4/6/23	3/29/24	3/4/25	3/31/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
RADNOSTIX, INC.	-	-	-	-	26.09M
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.50x	7.04x	18.69x	2.12%	400.37B
Weighted average by Cap.	35.23x	8.29x	20.39x	1.8%